Treatment of diabetic rats with encapsulated islets

Journal of Cellular and Molecular Medicine

Volumn 12, Issue 6B, 2008, Pages 2644-2650

  Sweet, Ian R ^a   Yanay, Ofer ^b   Waldron, Lanaya ^b   Gilbert, Merle ^a   Fuller, Jessica M ^a   Tupling, Terry ^a   Lernmark, Ake ^a   Osborne, William R A ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

BB rats; Bioisolator; Diabetes; Islets; STZ

Indexed keywords

STREPTOZOCIN;

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BODY WEIGHT; EXPERIMENTAL DIABETES MELLITUS; FEMALE; IMPLANTATION; MALE; PANCREAS ISLET TRANSPLANTATION; RAT;

ANIMALS; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; PROSTHESIS IMPLANTATION; RATS; STREPTOZOCIN; TRANSPLANTATION, HOMOLOGOUS;

RATTUS;

EID: 55049090829     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00322.x     Document Type: Article

References (44)

1. Crofford OB. Diabetes control and complications. Ann Rev Med. 1995 46 : 267 79.
2. Falorni A, Kockum I, Sanjeevi CB, Lernmark A. Pathogenesis of insulin-dependent diabetes mellitus. Bailliere's Clin Endocrinol Met. 1995 9 : 25 46.
3. Rubin RR, Peyrot M. Implications of the DCCT. Looking beyond tight control. Diabetes Care. 1994 17 : 235 6.
4. (DCCT) The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. Ann Inter Med. 1998 128 : 517 23.
5. Borch-Johnsen K, Kreiner S, Deckert T. Mortality of Type 1 (insulin-dependent) diabetes mellitus in Denmark: a study of relative mortality in 2930 Danish Type 1 diabetic patients diagnosed from 1933 to 1972. Diabetologia. 1986 29 : 767 72.
6. Lagasse JM, Brantley MS, Leech NJ, Rowe RE, Monks S, Palmer JP, Nepom GT, McCulloch DK, Hagopian WA. Sucessful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies. Diabetes Care. 2002 25 : 505 11.
7. Becker TC, Noel RJ, Coats WS, Gomez-Foix AM, Alam T, Gerard RD, Newgard CB. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods in Cell Biol. 1994 43 : 161 89.
8. Levine F, Leibowitz G. Towards gene therapy of diabetes mellitus. Mol Med Today. 1999 5 : 165 71.
9. Newgard CB. While tinkering with the β-cell... Metabolic regulatory mechanisms and new therapeutic strategies. Diabetes. 2002 51 : 3141 50.
10. Giannoukakis N, Rudert W, Robbins P, Trucco M. Targeting autoimmune diabetes with gene therapy. Diabetes. 1999 48 : 2107 21.
11. Papas KK, Long RCJ, Constantinidis I, Sambanis A. Effects of short-term hypoxia on a transformed cell-based bioartificial pancreatic construct. Cell Transplant. 2000 9 : 415 22.
12. Constantinidis I, Long RJ, Weber C, Safley S, Sambanis A. Non-Invasive monitoring of a bioartificial pancreas in vitro and in vivo. Ann N Y Acad Sci. 2001 944 : 83 95.
13. Papas KK, Long RCJ, Sambanis A, Constantinidis I. Development of a bioar-tificial pancreas: II. Effects of oxygen on long-term entrapped betaTC3 cell cultures. Biotechnol Bioeng. 1999 66 : 231 7.
14. Sullivan SJ, Maki T, Borland KM, Mahoney MD, Solomon BA, Muller TE, Monaco AP, Chick WL. Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. Science. 1991 252 : 718 21.
15. Lacy PE, Hegre OD, Gerasimidi-Vazeou A, Gentile FT, Dionne KD. Maintenance of normoglycemia in diabetic mice by subcutaneous zenografts of encapsulated islets. Science. 1991 254 : 1782 4.
16. Loudovaris T, Jacobs S, Young S, Maryanov D, Brauker J, Johnson RC. Correction of diabetic nod mice with insulinomas implanted within Baxter immunoisolation devices. J Mol Med. 1999 77 : 219 22.
17. Josephs SF, Loudovaris T, Dixit A, Young SK, Johnson RC. In vivo delivery of recombinant human growth hormone from genetically engineered human fibroblasts implanted within Baxter immunoisolation devices. J Mol Med. 1999 77 : 211 4.
18. Tibell A, Rafael E, Wennberg L, Nordenström J, Bergström M, Geller RL, Loudovaris T, Johnson RC, Brauker JH, Neuenfeldt S, Wernerson A. Survival of macroencapsulated allogeneic parathyroid tissue one year after transplantation in nonimmunosuppressed humans. Cell Transplant. 2001 10 : 591 9.
19. Trivedi N, Steil GM, Colton CK, Bonner-Weir S, Weir GC. Improved vasculariza-tion of planar membrane diffusion devices following continuous infusion of vascular endothelial growth factor. Cell Transplant. 2000 9 : 115 24.
20. Rafael E, Wernerson A, Arner P, Wu GS, Tibell A. In vivo evaluation of glucose permeability of an immunoisolation device intended for islet transplantation: a novel application of the microdialysis technique. Cell Transplant. 1999 8 : 317 26.
21. Dionne KE, Colton CK, Yarmush ML. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes. 1993 42 : 12 21.
22. Colton CK. Oxygen requirements of islets. In Encapsulation and Immunaoprotective Strategies of Islet Cells Workshop Proceedings Report, December 6-7, Washington DC. RT International. 2001 9 10.
23. Avgoustiniatos ES, Colton CK. Effect of external oxygen mass transfer resistances on viability of immunoisolated tissue. Ann N Y Acad Sci. 1997 831 : 145 67.
24. Yanay O, Flint LY, Brzezinski M, Barry SC, Barton RW, Osborne WRA. Long-term erythropoietin gene expression from transduced cells in bioisolator devices. Hum. Gene Ther. 2003 14 : 1587 93.
25. Ramanathan S, Poussier P. BB rat lyp mutation and Type 1 diabetes. Immunol. Rev. 2001 184 : 161 71.
26. Bieg S, Simonson WT, Elefson K, Lernmark Å. Rel B is an early marker of autoimmune islet inflammation in the bio-breeding (BB) rat. Pancreas. 2000 20 : 47 54.
27. MacMurray AJ, Moralejo DH, Kwitek AE, Rutledge EA, Van Yserloo B, Gohlke P, Speros SJ, Snyder B, Schaefe rJ, Bieg S, Jiang J, Ettinger R, Fuller J, Daniels T, Pettersson A, Orlebeke K, Birren B, Jacob H, Lander E, Lernmark A. Lymphopenia in the BB Rat Model of Type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. Genome Res. 2002 12 : 1029 39.
28. Bieg S, Koike G, Jiang J, Klaff L, Pettersson A, MacMurray AJ, Jacob HJ, Lander ES, Lernmark Å. Genetic isolation of the Lyp region on chromosome 4 in the diabetes prone BioBreeding (BB) rat. Mammalian Genome. 1998 9 : 324 6.
29. Jorns A, Klempnauer J, Tiedge M, Lenzen S. Recovery of pancreatic beta cells in response to long-term normoglycemia after pancreas or islet transplantation in severely streptozotocin diabetic adult rats. Pancreas. 2001 23 : 186 96.
30. Sweet IR, Wallen AR, Khalil G, Callis JB, Steedman M, Lernmark A. Continuous assessment of metabolic and mitochondr-ial function of pancreatic islets. Diabetes Technol Ther. 2002 4 : 661 72.
31. Sweet IR, Cook DL, DeJulio E, Wallen AR, Khalil G, Callis J, Reems J. Regulation of ATP/ADP in pancreatic islets. Diabetes. 2004 53 : 401 9.
32. Sweet IR, Gilbert M, Jensen R, Sabek O, Fraga DW, Gaber AO, Reems J. Glucose stimulation of cytochrome C reduction and oxygen consumption as assessment of human islet quality. Transplantation. 2005 80 : 1003 11.
33. Sweet IR, Gilbert M. Contribution of calcium influx in mediating glucose-stimulated oxygen consumption in pancreatic islets 10.2337/db06-0400. Diabetes. 2006 55 : 3509 19.
34. Taneda S, Segerer S, Hudkins KL, Cui Y, Wen M, Segerer M, Wener MH, Khairallah CG, Farr AG, Alpers CE. Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol. 2001 159 : 2355 69.
35. Pileggi A, Molano RD, Ricordi C, Zahr E, Collins J, Valdes R, Inverardi L. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation. 2006 81 : 1318 24.
36. Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000 343 : 230 8.
37. Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology. 2003 144 : 5149 58.
38. De Leon DD, Deng S, Madani R, Ahima RS, Drucker DJ, Stoffers DA. Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes. 2003 52 : 365 71.
39. Fenjves ES, Ochoa MS, Cabrera O, Mendez AJ, Kenyon NS, Inverardi L, Ricordi C. Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors. Transplantation. 2003 75 : 1356 60.
40. Fenjves ES, Ochoa MS, Gay-Rabinstein C, Molano RD, Pileggi A, Mendez AJ, Inverardi L, Ricordi C. Adenoviral gene transfer of erythropoietin confers cytopro-tection to isolated pancreatic islets. Transplantation. 2004 77 : 13 8.
41. Kim S, Wan Kim S, Bae YH. Synthesis, bioactivity and specificity of glucagon-like peptide-1 (7-37)/polymer conjugate to isolated rat islets. Biomaterials. 2005 26 : 3597 606.
42. Kim YY, Chae SY, Kim S, Byun Y, Bae YH. Improved phenotype of rat islets in a macrocapsule by co-encapsulation with cross-linked Hb. J Biomater Sci Polym Ed. 2005 16 : 1521 35.
43. Sigrist S, Mechine-Neuville A, Mandes K, Calenda V, Braun S, Legeay G, Bellocq J-P, Pinget M, Kessler L. Influence of VEGF on the viability of encapsulated pancreatic rat islets after transplantation in diabetic mice. Cell Transplant. 2003 12 : 627 35.
44. Dupraz P, Rinsch C, Pralong WF, Rolland E, Zufferey R, Trono D, Thorens B. Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion. Gene Ther. 1999 6 : 1160 9.